IDH1 and astrocytoma (excluding glioblastoma): Such strong differences between both types of astrocytomas can be expected because IDH mutations alter a great variety of molecular processes including energy metabolism, epigenetic reprogramming, cell differentiation, tumor microenvironment, and glioma invasion with impacts on therapy responses [43,46,47].